Cynthia L. Feldmann net worth and biography

Cynthia Feldmann Biography and Net Worth

Director of STERIS

Cynthia L. Feldmann director since March 2005 and President and Founder of Jetty Lane Associates, a consulting firm, from December 2005 to December 2011. Ms. Feldmann is a retired certified public accountant with 27 years of experience in two large global accounting firms. From 2003 to 2005, Ms. Feldmann served as the Life Sciences Business Development Officer for the Boston law firm Palmer & Dodge, LLP. From 1994 to 2002, Ms. Feldmann was a partner with KPMG LLP, primarily serving as Partner-in-Charge of its National Medical Technologies Practice. From 1975 to 1994, Ms. Feldmann was employed by Coopers & Lybrand (now PricewaterhouseCoopers LLP), and during that time was named Partner-in-Charge of its Life Sciences practice. Ms. Feldmann has a Bachelor of Science, Accounting, and holds a Master Professional Director Certification from the American College of Corporate Directors. Ms. Feldmann served as a director of HeartWare International, Inc. until August 2016 and served as a director of Hanger, Inc. until January 2018. Ms. Feldmann is a director of, and a member of the Nominating Committee and chair of the Audit Committee of, UFP Technologies, Inc. and is a director of and serves on the Audit Committee of Frequency Therapeutics.

What is Cynthia L. Feldmann's net worth?: The estimated net worth of Cynthia L. Feldmann is at least $910,617.40 as of February 23rd, 2024. Ms. Feldmann owns 4,466 shares of STERIS stock worth more than $910,617 as of April 28th. This net worth approximation does not reflect any other investments that Ms. Feldmann may own. Learn More about Cynthia L. Feldmann's net worth.
How do I contact Cynthia L. Feldmann?: The corporate mailing address for Ms. Feldmann and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Cynthia L. Feldmann's contact information.
Has Cynthia L. Feldmann been buying or selling shares of STERIS?: Cynthia L. Feldmann has not been actively trading shares of STERIS during the past quarter. Most recently, Cynthia L. Feldmann sold 1,891 shares of the business's stock in a transaction on Thursday, February 10th. The shares were sold at an average price of $234.10, for a transaction totalling $442,683.10. Learn More on Cynthia L. Feldmann's trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 5/15/2023.

Cynthia L. Feldmann Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/10/2022	Sell	1,891	$234.10	$442,683.10
5/25/2021	Sell	4,000	$190.84	$763,360.00	2,815
2/20/2019	Sell	2,037	$122.51	$249,552.87	10,700
2/26/2018	Sell	3,218	$91.35	$293,964.30	11,214
11/4/2016	Sell	4,744	$64.98	$308,265.12	14,581
8/9/2012	Sell	23,122	$34.05	$787,304.10

Cynthia L. Feldmann Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $203.90

$200.45

$204.64

50 Day Range

MA: $221.18

$198.94

$236.03

2 Week Range

Now: $203.90

$181.78

$254.00

Volume

318,142 shs

Average Volume

558,812 shs

Market Capitalization

$20.15 billion

P/E Ratio

35.71

Dividend Yield

1.02%

Beta

0.79

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy